New Findings on Blood Vessel Regulation
A study from an RPB-supported researcher at Northwestern University School of Medicine could speed up the diagnosis of retinal diseases.
RPB-SUPPORTED RESEARCHERS INTEGRAL TO NEI’S AUDACIOUS GOALS INITIATIVE
Vision scientists who have received RPB funding will help lead all five research teams, which will seek to accelerate development of regenerative treatments for blindness.
EMERGING VISION SCIENTISTS EDUCATE, THANK CONGRESS FOR RESEARCH APPROPRIATIONS
(NAEVR) held its Fourth Annual Emerging Vision Scientists (EVS) Day on Capitol Hill and twenty early-stage investigators participated.
RPB AND LCIF TO CONTINUE LOW VISION RESEARCH AWARD PARTNERSHIP
Research to Prevent Blindness (RPB) and Lions Clubs International Foundation (LCIF) announced today that they will continue their partnership in the RPB/LCIF Low Vision Research Award.
RPB researchers honored with 2018 António Champalimaud Vision Award
Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research
IN THE FUTURE, ALZHEIMER’S MAY BE PREDICTED DURING EYE EXAMS
RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.
RPB and AUPO Announce Recipient of RPB David F. Weeks Award for Outstanding AMD Research
RPB and AUPO announce the 2018 recipient of the award focused on age-related macular degeneration.
Groundbreaking Gene Therapy for Retinal Disease
The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.
RPB and AAO Award Grants for Big Data Research to Advance Patient Care
Award recipients to use IRIS Registry database to conduct population-based studies.
Research to Prevent Blindness Expands Grants Program
Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.
Study Tests Stem Cell-based Therapy for Advanced Dry AMD
RPB-supported researchers at the University of Southern California Roski Eye Institute conducted the human trial.
Study Links Aging Immune Cells and AMD
RPB-supported researchers at Washington University School of Medicine in St. Louis published the new findings.
Subscribe
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
| General Info | Research Scientists & Grantees | Eye Care Specialists | Donors & Partners |
Research to Prevent Blindness
360 Lexington Avenue, 22nd Floor
New York, NY 10017
(212) 752-4333
Copyright © 2018 Research to Prevent Blindness. All Rights Reserved.
